DHR
Ticker
Danaher Corp
Company
LifeSciences
Industry
Healthcare
Sector
+
2009
+
2010
+
2011
+
2012
+
2013
+
2014
+
2015
+
2016
+
2017
+
2018
+
2019
+
2020
+
2021
+
2022
+
2023
+
2024
+
2025
TTM
Revenue Growth YoY
18.0%21.9%13.5%4.7%4.2%5.0%-4.9%-7.8%8.5%0.2%11.7%32.2%6.9%-12.3%-13.5% 2.2%
Revenue Growth QoQ
Gross Margin
47.2%50.2%50.8%51.6%52.1%52.4%52.7%54.3%55.6%55.8%55.7%56.0%61.0%60.2%58.7%59.5% 59.5%
EBITDA Margin
16.8%19.4%20.2%21.9%21.8%21.9%21.7%22.5%23.2%23.7%23.0%29.0%32.7%34.7%29.6%30.2% 29.0%
Operating Margin
13.8%16.4%16.3%17.3%17.1%17.2%16.7%16.8%16.5%17.1%17.1%19.0%25.3%27.6%21.7%20.4% 19.0%
Profit Margin
10.3%13.6%13.5%13.1%14.1%13.0%16.1%12.8%13.6%13.3%15.1%16.4%21.8%22.9%17.3%16.3% 14.4%
FCF / EBITDA
85.6%72.8%70.5%73.8%72.8%72.3%69.9%65.6%67.1%71.4%72.2%83.8%73.3%67.5%70.8%73.4% 71.3%